ArticleCureus2025
Radial Endobronchial Ultrasound for the Diagnosis of Peripherally Located Pulmonary Lesions.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Peripheral pulmonary lesions (PPLs) pose a significant diagnostic challenge for the clinician as they are not visualized within the bronchial tree during flexible bronchoscopy. Radial endobronchial ultrasound (EBUS) is a minimally invasive bronchoscopic technique that expands the view of the bronchoscopist beyond the lumen of the airway, offering a promising diagnostic modality for PPLs. Objectives To assess the types of different peripheral pulmonary lesions diagnosed by radial endobronchial ultrasound-guided biopsy, and also to assess the agreement between the findings of radiological imaging and radial EBUS-guided biopsy in determining benign and malignant peripheral pulmonary lesions. Methodology This was a cross-sectional study performed on 40 patients aged ≥18 years with radiological evidence of PPLs who attended the respiratory medicine outpatient department (OPD) of the Regional Institute of Medical Sciences (RIMS), Imphal, Manipur, from April 2023 to March 2025. Results This study determined the diagnostic yield of radial EBUS to be 77.5%. Among the malignant lesions diagnosed, adenocarcinoma (15 patients, 37.5%) was the most common histopathological type followed by squamous cell carcinoma (eight patients, 20%) and small cell carcinoma (one patient, 2.5%) while benign lesions included pulmonary tuberculosis (five patients, 12.5%) and pulmonary aspergillosis (two patients, 5%). Substantial agreement (Kappa=0.674, p<0.001) was found between CT diagnosis and radial EBUS transbronchial lung biopsy (TBLB) findings in classifying lesions as benign or malignant. Conclusion In this study, radial EBUS-guided TBLB was found to be a safe and effective diagnostic modality for PPLs, offering high diagnostic yield and strong concordance with imaging findings, reinforcing its value in clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.